Reduced asymmetric dimethylarginine (ADMA) levels mediate in the protection from metabolic syndrome by smoking

被引：6
作者：
Onat, Altan [2 ]
Hergenc, Guelay [1 ]
机构：
[1] Yildiz Tech Univ, Dept Biol, Istanbul, Turkey
[2] Istanbul Univ, Cerrahpasa Med Fac, Istanbul, Turkey
来源：
ATHEROSCLEROSIS | 2008年 / 196卷 / 01期
关键词：
asymmetric dimethylarginine; cigarette smoking; insulin resistance; metabolic syndrome; obesity;
D O I：
10.1016/j.atherosclerosis.2006.10.040
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：479 / 480
页数：2
相关论文
共 50 条
  • [41] Effects of virgin coconut oil consumption on metabolic syndrome components and asymmetric dimethylarginine: A randomized controlled clinical trial
    Nikooei, Parinaz
    Hosseinzadeh-Attar, Mohammad J.
    Asghari, Somayyeh
    Norouzy, Abdolreza
    Yaseri, Mehdi
    Vasheghani-Farahani, Ali
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2021, 31 (03) : 939 - 949
  • [42] Plasma asymmetric dimethylarginine and L-arginine levels in patients with cardiac syndrome X
    Okyay, Kaan
    Cengel, Atiye
    Sahinarslan, Asife
    Tavil, Yusuf
    Turkoglu, Sedat
    Biberoglu, Gulser
    Hasanoglu, Alev
    CORONARY ARTERY DISEASE, 2007, 18 (07) : 539 - 544
  • [43] Evaluation of serum neutrophil gelatinase-associated lipocalin (NGAL), asymmetric dimethylarginine (ADMA) and symmetric dimethylarginine (SDMA) levels, and their relations with disease type and activity in inflammatory bowel diseases
    Korkmaz, Huseyin
    Asil, Mehmet
    Temel, Tuncer
    Ozturk, Bahadir
    Kebapcilar, Levent
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2021, 51 (05) : 2403 - 2412
  • [44] The Relationship Between Serum Asymmetric Dimethylarginine Levels and Cardiovascular Risk Factors in Children with Nephrotic Syndrome
    Aksu, Bagdagul
    Emre, Sevinc
    Yilmaz, Alev
    Yuruk, Zeynep Nagehan
    Demirel, Umit Dilber Mutlu
    Erol, Oguz Bulent
    Pehlivanoglu, Cemile
    HASEKI TIP BULTENI-MEDICAL BULLETIN OF HASEKI, 2019, 57 (02): : 122 - 128
  • [45] The usefulness of plasma asymmetric dimethylarginine (ADMA) levels and tissue doppler echocardiography for heart function in term infants born to mothers with gestational diabetes mellitus
    Arslan, Derya
    Oran, Bulent
    Vatansev, Husamettin
    Cimen, Derya
    Guvenc, Osman
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2013, 26 (17) : 1742 - 1748
  • [46] Serum asymmetric dimethylarginine (ADMA), homocysteine, vitamin B12, folate levels, and lipid profiles in epileptic children treated with valproic acid
    Ozlem Ozdemir
    Ayten Yakut
    Ener Cagri Dinleyici
    Sultan Durmus Aydogdu
    Coskun Yarar
    Omer Colak
    European Journal of Pediatrics, 2011, 170 : 873 - 877
  • [47] Serum asymmetric dimethylarginine (ADMA), homocysteine, vitamin B12, folate levels, and lipid profiles in epileptic children treated with valproic acid
    Ozdemir, Ozlem
    Yakut, Ayten
    Dinleyici, Ener Cagri
    Aydogdu, Sultan Durmus
    Yarar, Coskun
    Colak, Omer
    EUROPEAN JOURNAL OF PEDIATRICS, 2011, 170 (07) : 873 - 877
  • [48] Predictive value of asymmetric dimethylarginine and C-reactive protein for the risk of developing metabolic syndrome in middle-aged men
    Otsuka, Toshiaki
    Nishiyama, Yasuhiro
    Kachi, Yuko
    Kato, Katsuhito
    Inagaki, Hirofumi
    Kawada, Tomoyuki
    IJC METABOLIC & ENDOCRINE, 2014, 5 : 42 - 47
  • [49] Increased asymmetric dimethylarginine (ADMA) levels and decreased homocysteine thiolactonase/paraoxonase (HTLase/PONase) activities are related to the risk of cardiovascular disease in prediabetic/diabetic patients
    Bayrak, Tulin
    Bayrak, Ahmet
    Isildak, Mehlika
    Cakir, Erdinc
    Gurlek, Alper
    Akbiyik, Filiz
    TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI, 2014, 39 (03): : 270 - 276
  • [50] The effect of exenatide (a GLP-1 analogue) and sitagliptin (a DPP-4 inhibitor) on asymmetric dimethylarginine (ADMA) metabolism and selected biomarkers of cardiac fibrosis in rats with fructose-induced metabolic syndrome
    Wojcicka, G.
    Pradiuch, A.
    Fornal, E.
    Stachniuk, A.
    Korolczuk, A.
    Marzec-Kotarska, B.
    Nikolaichuk, H.
    Czechowska, G.
    Kozub, A.
    Trzpil, A.
    Goralczyk, A.
    Beltowski, J.
    BIOCHEMICAL PHARMACOLOGY, 2023, 214
12345